Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Rossi

Showing results (171-180 of 194) with videos related to

Pageof 20
Sort By:
Blood|May 3, 2013
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemiaDavide Rossi, Valeria Spina, Riccardo Bomben, et al.
British Journal of Haematology|November 28, 2008
Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre studyRiccardo Bomben, Michele Dal Bo, Daniela Capello, et al.
Breast Cancer Research : BCR|May 14, 2025
ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapyKonstantinos Venetis, Giulia Cursano, Roberta Scafetta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological featuresRiccardo Bomben, Michele Dal-Bo, Dania Benedetti, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Guidance on the use of the Threshold of Toxicological Concern approach in food safety assessment, Simon J More, Vasileios Bampidis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2016
Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative GroupLuiz Fernando Lopes, Carla Renata Pacheco Donato Macedo, Simone Dos Santos Aguiar, et al.
Genes, Chromosomes & Cancer|May 13, 2011
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemiaMichele Dal Bo, Francesca Maria Rossi, Davide Rossi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2017
PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination TherapyChiara Tarantelli, Eugenio Gaudio, Alberto J Arribas, et al.
Haematologica|October 5, 2019
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemiaJared A Cohen, Francesca Maria Rossi, Antonella Zucchetto, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 14, 2014
Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene eraAlessandro Martino, Daniele Campa, Artur Jurczyszyn, et al.
Pageof 20

Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Blood|May 3, 2013
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemiaDavide Rossi, Valeria Spina, Riccardo Bomben, et al.
British Journal of Haematology|November 28, 2008
Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre studyRiccardo Bomben, Michele Dal Bo, Daniela Capello, et al.
Breast Cancer Research : BCR|May 14, 2025
ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapyKonstantinos Venetis, Giulia Cursano, Roberta Scafetta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological featuresRiccardo Bomben, Michele Dal-Bo, Dania Benedetti, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Guidance on the use of the Threshold of Toxicological Concern approach in food safety assessment, Simon J More, Vasileios Bampidis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2016
Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative GroupLuiz Fernando Lopes, Carla Renata Pacheco Donato Macedo, Simone Dos Santos Aguiar, et al.
Genes, Chromosomes & Cancer|May 13, 2011
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemiaMichele Dal Bo, Francesca Maria Rossi, Davide Rossi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2017
PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination TherapyChiara Tarantelli, Eugenio Gaudio, Alberto J Arribas, et al.
Haematologica|October 5, 2019
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemiaJared A Cohen, Francesca Maria Rossi, Antonella Zucchetto, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 14, 2014
Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene eraAlessandro Martino, Daniele Campa, Artur Jurczyszyn, et al.
Pageof 20